Home

The Global Network for Women’s and Children’s Health Research (Global Network) is a partnership dedicated to improving maternal and child health outcomes and building health research capacity in resource-poor settings by testing cost-effective, sustainable interventions that provide guidance for the practice of evidence-based medicine.

News


Closer and closer? Maternal immunization: current promise, future horizons Link

June 22, 2020:

This state-of-the art manuscript highlights our current understanding of maternal immunization—the practice of vaccinating pregnant women to confer protection on them as well as on young infants, and thereby reduce vaccine-preventable morbidity and mortality. Read More »

 

FNIH Launches Project Testing Antibiotic to Prevent Infections in Mothers and Newborns Attachment Link

June 03, 2020:

The Foundation for the National Institutes of Health (FNIH) has announced a new project that will test whether an antibiotic taken during labor prevent infections in mothers and newborns in seven low- and middle-income countries. Read More »

 

Stories From the Field: Zambia Attachment Link

June 01, 2020:

In the latest Stories from the Field article, Dr. Musaku Mwenechanya describes his experience working with the Global Network in Zambia over the past seven years. He outlines the barriers to healthcare that mothers and infants face in rural Zambia, and how his team hopes to use the data generated through Global Network trials to develop policy and sustainable solutions alongside the national government affecting critical maternal and child outcomes.  

 

COVID Realities From the Field: Bangladesh Link

May 08, 2020:

This week we talk to Dr. Rashidul Haque at icddr,b to learn about what the GN Bangladesh team is doing to adapt their practices and how they are keeping motivated and engaged.


https://globalnetwork.azurewebsites.net/About-Us/GN-COVID-Response-Site-Adaptations

 

Notice of Special Interest: Administrative Supplements for NIH grants to Add or Expand Research Focused on Maternal Mortality Link

May 06, 2020:

The Office of the Director of the National Institutes of Health (NIH) announces the opportunity for investigators with relevant active NIH-supported grants from the participating Institutes listed above to the scientific priorities that will lay the foundation for the Implementing a Maternal health and PRegnancy Outcomes Vision for Everyone (IMPROVE), which is in development.

Please access the link to the Notice of Special Interest: Administrative Supplements for NIH grants to Add or Expand Research Focused on Maternal Mortality.

 

Recent Publications

Low-dose aspirin for the prevention of preterm delivery in nulliparous women with a singleton pregnancy (ASPIRIN): a randomised, double-blind, placebo-controlled trial

Hoffman MK, Goudar SS, Kodkany BS, Metgud M, Somannavar M, Okitawutshu J, Lokangaka A, Tshefu A, Bose CL, Mwapule A, Mwenechanya M, Chomba E, Carlo WA, Chicuy J, Figueroa L, Garces A, Krebs NF, Jessani S, Zehra F, Saleem S, Goldenberg RL, Kurhe K, Das P, Patel A, Hibberd PL, Achieng E, Nyongesa P, Esamai F, Liechty EA, Goco N, Hemingway-Foday J, Moore J, Nolen TL, McClure EM, Koso-Thomas M, Miodovnik M, Silver R, Derman RJ, Achieng E, Bauserman M, Bose C, Bucher S, Carlo W, Chicuy J, Chomba E, Das P, Derman R, Esamai F, Figueroa L, Garces A, Goco N, Goldenberg R, Goudar S, Hemingway-Foday J, Hibberd P, Hoffman M, Jessani S, Krebs N, Kodkany B, Koso-Thomas M, Kurhe K, Liechty E, Lokangaka A, MacGuire E, McClure E, Metgud M, Miodovnik M, Moore J, Mwapule A, Mwenechanya M, Naqvi F, Naqvi S, Nathan R, Nolen T, Nyongesa P, Okitawutshu J, Parepalli S, Patel A, Saleem S, Silver R, Somannavar M, Soomro Z, Tshefu A, Wallace D, Zehra F. Low-dose aspirin for the prevention of preterm delivery in nulliparous women with a singleton pregnancy (ASPIRIN): a randomised, double-blind, placebo-controlled trial The Lancet. 2020 1; 395(10220): . PubMed: 31982074 Protocols: ASPIRIN View

Preconception nutrition intervention improved birth length and reduced stunting and wasting in newborns in South Asia: The Women First Randomized Controlled Trial.

Dhaded SM, Hambidge KM, Ali SA, Somannavar M, Saleem S, Pasha O, Khan U, Herekar V, Vernekar S, Kumar S Y, Westcott JE, Thorsten VR, Sridhar A, Das A, McClure E, Derman RJ, Goldenberg RL, Koso-Thomas M, Goudar SS, Krebs NF. Preconception nutrition intervention improved birth length and reduced stunting and wasting in newborns in South Asia: The Women First Randomized Controlled Trial. PLoS ONE. 2020 ; 15(1): e0218960. PubMed: 31995570 PubMed Central: PMC6988936 Protocols: Women First View

Maternal Characteristics Affect Fetal Growth Response in the Women First Preconception Nutrition Trial.

Hambidge KM, Bann CM, McClure EM, Westcott JE, Garcés A, Figueroa L, Goudar SS, Dhaded SM, Pasha O, Ali SA, Derman RJ, Goldenberg RL, Koso-Thomas M, Somannavar MS, Herekar V, Khan U, Krebs NF. Maternal Characteristics Affect Fetal Growth Response in the Women First Preconception Nutrition Trial. Nutrients. 2019 Oct; 11(10): . PubMed: 31640153 PubMed Central: PMC6835723 Protocols: Women First View
View All Publications
Copyright 2020 Global Network
Tidy - A Free Responsive DotNetNuke Skin